endopromag
Advertisement
  • Home
  • News
  • Magazine
    • Current Issue
    • Past Issues
  • Online Content
    • Articles
    • References
    • Education
    • Products
    • Videos
  • Subscribe
  • About us
  • Contact us
No Result
View All Result
endopromag
No Result
View All Result
Home Covid-19

New study sheds light on IBD patients with COVID-19

endopromag_adn by endopromag_adn
October 5, 2023
in Covid-19, IBD, Inflammatory Bowel Disease
0
New study sheds light on IBD patients with COVID-19
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter
In an upcoming study to be published in Gastroenterology, researchers at the Icahn School of Medicine at Mount Sinai and the University of North Carolina School of Medicine report on the clinical course of COVID-19 and risk factors for adverse outcomes in a large cohort of patients with IBD collected through an international registry. When the COVID-19 epidemic started to unfold around the country, the researchers collaborated to form an international registry of patients who have inflammatory bowel disease (IBD) and COVID-19. The registry, Surveillance Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD), to date includes 528 patients from 33 countries. “We established the registry to better characterize the clinical course of COVID-19 within the IBD patient population and evaluate the association between demographics, clinical characteristics, and IBD treatments on COVID-19 outcomes,” said study co-author, Erica Brenner, MD, Pediatric Gastroenterology Fellow, UNC Children’s Hospital. The researchers conclude that increasing age, comorbidities, and corticosteroids are associated with severe COVID-19 among IBD patients, although a causal relationship cannot be definitively established. Notably, TNF antagonists do not appear to be associated with severe COVID-19. “One of our main takeaways for the IBD patient population is that maintaining remission with steroid-sparing treatments will be important through this pandemic. Our finding that TNF antagonist therapy is not associated with severe COVID-19 is reassuring news in light of the large number of patients who require this therapy, currently the most commonly prescribed biologic therapy for IBD patients,” said study co-author, Ryan Ungaro, MD, Assistant Professor, Icahn School of Medicine at Mount Sinai and a gastroenterologist with Mount Sinai Hospital’s Feinstein IBD Center. Source: University of North Carolina
Tags: COVID-19News
Share30Tweet19

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Browse by Category

ADVERTISEMENT

Related News

Newest Free CEU Game Released on Crazy4Clean.com: “EndoGal”

Newest Free CEU Game Released on Crazy4Clean.com: “EndoGal”

October 16, 2023
Colorectal cancer statistics, 2017

Colorectal cancer statistics, 2017

October 16, 2023
Crohn’s & Colitis Foundation Launches New IBD Clinical Trials Community to Educate and Support Clinical Trial Participation

Crohn’s & Colitis Foundation Launches New IBD Clinical Trials Community to Educate and Support Clinical Trial Participation

October 16, 2023

Tags

AAMI AORN Award Bacteria BIOCHEMISTRY biology cancer CBSPD Chemotherapy colon cancer colorectal cancer colorectal cancer screening COVID-19 CRC Digestive Health Duodenoscope Education EndoPro Magazine Endoscope Endoscopy FDA gastroenterology gastrointestinal disorders Genetics GI Healthcare Healthmark IAHCSMM IBD IBS Infections Internal medicine irritable bowel syndrome Medicine MEDICINE/HEALTH Microbiology News Nursing polyps PPE Public Health recall Screening SGNA Studies
endopromag

EndoPro Magazine is the award winning advocate for today’s endoscopy profession. We are the go-to source for endoscopy nurses, technicians, and their colleagues in hospitals, ambulatory care centers, and free-standing endoscopy facilities in the United States and abroad.

Browse by Topic

Anal CancerAntibiotic Resistance

C. diffCancerCentral Services

ColitisDiet/Body WeightEquipment

ERCPGastroenterologyView All

Current Issue

CURRENT ISSUE CURRENT ISSUE CURRENT ISSUE

© 2023 Copyright. All Rights Reserved. Design & Developed by Insightful Technologies.

No Result
View All Result
  • Home
  • News
  • Magazine
    • Current Issue
    • Past Issues
  • Online Content
    • Articles
    • References
    • Education
    • Products
    • Videos
  • Subscribe
  • About us
  • Contact us

© 2023 Copyright. All Rights Reserved. Design & Developed by Insightful Technologies.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?
Go to mobile version